Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Jul 07, 2016 $26.91 $27.38 $26.57 $26.72 96 300
Jul 06, 2016 $26.03 $26.98 $25.86 $26.83 89 300
Jul 05, 2016 $27.25 $27.25 $26.18 $26.52 50 500
Jul 01, 2016 $26.77 $27.47 $26.59 $27.25 148 800
Jun 30, 2016 $27.08 $27.18 $26.51 $26.59 91 600
Jun 29, 2016 $26.80 $26.84 $26.09 $26.67 135 200
Jun 28, 2016 $26.30 $26.86 $25.76 $25.97 123 600
Jun 27, 2016 $25.80 $26.10 $24.82 $25.34 98 100
Jun 24, 2016 $25.91 $27.46 $25.87 $26.61 199 100
Jun 23, 2016 $28.28 $29.09 $28.04 $28.90 105 600
Jun 22, 2016 $27.59 $28.31 $27.31 $27.82 69 100
Jun 21, 2016 $28.39 $28.42 $27.58 $27.69 117 700
Jun 20, 2016 $27.85 $28.05 $27.39 $27.78 87 300
Jun 17, 2016 $26.78 $27.12 $26.43 $26.70 97 200
Jun 16, 2016 $26.95 $27.00 $26.21 $26.95 85 035
Jun 15, 2016 $27.89 $28.22 $27.34 $27.69 148 315
Jun 14, 2016 $27.42 $28.50 $27.22 $27.89 207 839
Jun 13, 2016 $27.87 $28.99 $27.81 $28.91 185 779
Jun 10, 2016 $29.44 $29.82 $28.99 $29.48 192 458
Jun 09, 2016 $31.71 $32.06 $30.63 $31.01 133 016
Jun 08, 2016 $32.60 $32.88 $31.50 $32.70 139 567
Jun 07, 2016 $33.37 $33.45 $32.75 $32.99 114 562
Jun 06, 2016 $32.97 $34.23 $32.57 $33.64 131 197
Jun 03, 2016 $33.13 $33.25 $32.38 $32.65 102 264
Jun 02, 2016 $32.34 $33.22 $32.34 $33.16 100 499
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT